GSK Reports $16.5 Million of WVE Purchases

January 30, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by GSK plc.

The British multinational pharmaceutical company reported a purchase of $16.5 million in Wave Life Sciences Ltd $WVE.

Royce & Associates LP filed a 13G for Transcat Inc $TRNS revealing an initial stake of 5.32%.

Here’s The Hot Corner, with data through January 30, 2024:

In another Form 4, the CEO of Intel Corporation $INTC reported a purchase of 3,000 shares, equivalent to $130,083.

There was no unusual options activity to report.

Stay tuned. We’ll be back on Thursday with more insider activity.

Filed Under: